Nilotinib

• Post Date:

  Nov 24,2013

• Expiry Date:

  Nov 24,2014

• Detailed Description:

  Cas No. :641571-10-0 Miracpharma has developed many pharmaceutical projects with categories of anticancer, antithrombotic, antiviral, anti-inflammatory and antibiotic, etc (see www.miracpharma.com). we have applied over 70 patents include about 100 new compounds(new CAS RN) and a lot of new processes of over 30 kinds of APIs and intermediates. Using our strategy of patent protection, the product is good quality, low expenditure, convenient process and environment-friendly. We are looking for appropriate manufacturers of API or intermediates who can exploitation of our patents by mean of patent license or technology transfer. We are also looking for farseeing investors and copartners who can discuss patent license and assignment, co-operation and business, join hands and march forwards for the greater prosperous future with us.

• CAS Registry Number:

  641571-10-0

• Synonyms:

  ;Nilotinib;AMN 107;Benzamide, 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-;4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4 -pyridin-3-ylpyrimidin-2-yl)amino]benzamide Nilotinib(TINIBS );Nilotinib for research;Tasigna;Nilotinib & its intermediates (Developing);Nilotinib, AMN107, Tasigna;4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}benzamide;

• Molecular Formula:

  C₂₈H₂₂F₃N₇O

• Molecular Weight:

  529.5158

• Molecular Structure:

  

• Company:

  Suzhou MiracPharma Technology Co., Ltd     [ China ]        

• Contact:

  X.Xu

• Tel:

  +86 18262008418

• Fax:

  -

• Email:

  manager@miracpharma.com